Northern Trust Corp Applied Therapeutics Inc. Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 774,317 shares of APLT stock, worth $425,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares
774,317
Previous 761,060 1.74%
Holding current value
$425,874
Previous $6.47 Million 89.83%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.82 - $10.24 $10,870 - $135,751
13,257 Added 1.74%
774,317 $658,000
Q3 2024

Nov 13, 2024
BUY
$4.35 - $8.5 $2.29 Million - $4.48 Million
527,276 Added 225.54%
761,060 $6.47 Million
Q2 2024

Aug 14, 2024
BUY
$4.04 - $6.37 $514,417 - $811,098
127,331 Added 119.61%
233,784 $1.09 Million
Q1 2024

May 14, 2024
SELL
$2.25 - $7.4 $324 - $1,065
-144 Reduced 0.14%
106,453 $723,000
Q4 2023

Feb 13, 2024
BUY
$1.84 - $3.35 $14,076 - $25,627
7,650 Added 7.73%
106,597 $357,000
Q3 2023

Nov 13, 2023
SELL
$1.26 - $2.77 $12,945 - $28,458
-10,274 Reduced 9.41%
98,947 $246,000
Q2 2023

Aug 11, 2023
BUY
$0.77 - $1.8 $44,860 - $104,869
58,261 Added 114.33%
109,221 $139,000
Q3 2022

Nov 14, 2022
BUY
$0.86 - $1.55 $13,217 - $23,821
15,369 Added 43.18%
50,960 $47,000
Q2 2022

Aug 12, 2022
SELL
$0.76 - $2.64 $97,881 - $340,010
-128,792 Reduced 78.35%
35,591 $34,000
Q1 2022

May 13, 2022
SELL
$1.48 - $6.22 $19,681 - $82,713
-13,298 Reduced 7.48%
164,383 $347,000
Q4 2021

Feb 08, 2022
SELL
$8.77 - $18.29 $4,551 - $9,492
-519 Reduced 0.29%
177,681 $1.59 Million
Q3 2021

Nov 15, 2021
SELL
$13.54 - $22.06 $159,826 - $260,396
-11,804 Reduced 6.21%
178,200 $2.96 Million
Q2 2021

Aug 13, 2021
BUY
$14.05 - $25.04 $155,041 - $276,316
11,035 Added 6.17%
190,004 $3.95 Million
Q1 2021

May 12, 2021
BUY
$16.57 - $28.65 $172,675 - $298,561
10,421 Added 6.18%
178,969 $3.36 Million
Q4 2020

Feb 11, 2021
SELL
$15.44 - $24.23 $59,629 - $93,576
-3,862 Reduced 2.24%
168,548 $3.71 Million
Q3 2020

Nov 16, 2020
BUY
$19.43 - $35.36 $1.22 Million - $2.22 Million
62,853 Added 57.37%
172,410 $3.58 Million
Q2 2020

Aug 14, 2020
BUY
$29.41 - $51.23 $209,134 - $364,296
7,111 Added 6.94%
109,557 $3.96 Million
Q1 2020

May 14, 2020
BUY
$19.54 - $55.47 $836,116 - $2.37 Million
42,790 Added 71.73%
102,446 $3.35 Million
Q4 2019

Feb 14, 2020
BUY
$10.16 - $28.14 $370,210 - $1.03 Million
36,438 Added 156.94%
59,656 $1.63 Million
Q3 2019

Nov 13, 2019
BUY
$8.08 - $10.99 $129,894 - $176,675
16,076 Added 225.09%
23,218 $256,000
Q2 2019

Aug 13, 2019
BUY
$8.1 - $10.05 $57,850 - $71,777
7,142 New
7,142 $59,000

Others Institutions Holding APLT

# of Institutions
129
Shares Held
111M
Call Options Held
1.1M
Put Options Held
800K
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $26.4M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email